Vivos Therapeutics Acquires Stake in SOD Sciences and 50% Test Interest
Vivos says the transaction is expected to add more than $10 million to stockholders' equity and open potential revenue opportunities through strategic alliances.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.